VA
BSX icon

Verdad Advisers’s Boston Scientific BSX Stock Holding History

Verdad Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$750K Sell
8,951
-2,129
-19% -$168K 1% 31
2024
Q2 		$853K Hold
11,080
– – 0.99% 35
2024
Q1 		$759K Buy
+11,080
New +$712K 0.83% 37

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Verdad Advisers's BSX Position: Q3 2024 in Review

Verdad Advisers reduced its Boston Scientific (BSX) stake by 19% in Q3 2024, selling an estimated $168K and leaving 8,951 shares worth $750K. The position accounts for 1% of the portfolio, ranked #31.

Verdad Advisers first reported a position in BSX in Q1 2024 and has held it in 3 quarters since. The position peaked at $853K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Verdad Advisers held 8,951 shares of Boston Scientific worth $750K as of Q3 2024.
  • Verdad Advisers sold 2,129 Boston Scientific shares in Q3 2024, an estimated $168K.
  • Boston Scientific made up 1% of Verdad Advisers's portfolio in Q3 2024, its #31 holding.
  • Verdad Advisers first reported a position in Boston Scientific in Q1 2024 and has held it in 3 quarters since.
  • Verdad Advisers's Boston Scientific position peaked at $853K in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Verdad Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.